Lifestyle as important as drugs in type-2 diabetes

Lifestyle interventions may be just as effective as drug therapy at preventing type-2 diabetes in patients with impaired glucose tolerance (IGT), research suggests.

Follow-up data from the Finnish Diabetes Prevention Study showed that a four-year intensive lifestyle intervention reduced the risk of type-2 diabetes by 43 per cent, even three years after intervention had ended. During active intervention, the risk of type-2 diabetes was cut by 58 per cent, said the research at Lancet Online.

This contrasts with data from the DREAM study, released in September, which showed that 8 mg daily rosiglitazone for three years in addition to lifestyle interventions reduced the risk of patients with IGT or impaired fasting glucose transferring to type-2 diabetes by 60 per cent.

Chairman of the Primary Care Diabetes Society, County Down GP Dr Colin Kenny, said: ‘Exercise intervention is a more effective intervention and more acceptable regarding side effects.  However, he added that ‘the intervention is really quite intensive, it would be much harder to transfer into the NHS.’

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...

BMA suspends GP committee election to investigate potential rule breach

BMA suspends GP committee election to investigate potential rule breach

The BMA has suspended voting in part of its GP committee election as it investigates...

Thousands of overseas GPs recognised for 'extraordinary contribution' to NHS

Thousands of overseas GPs recognised for 'extraordinary contribution' to NHS

GP leaders have recognised the extraordinary contribution of thousands of overseas-qualified...

GPs report concerns over BMA GP committee elections

GPs report concerns over BMA GP committee elections

Elections for nearly one in four regional BMA GP committee seats are underway, but...

UK hits 1m second doses of COVID-19 vaccine as campaign shifts to next phase

UK hits 1m second doses of COVID-19 vaccine as campaign shifts to next phase

More than 1m people UK-wide have now had two doses of COVID-19 vaccine, official...

What GPs need to know about the GMC's new guidance on prescribing

What GPs need to know about the GMC's new guidance on prescribing

MDU medico-legal adviser Kathryn Leask explains the key issues GPs need to be aware...